Cerebral Palsy

Developmental-Behavioral Pediatrics

Volumn , Issue , 2009, Pages 653-662

  Glader, Laurie ^a,b   Tilton, Ann ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Louisiana State Hlth Sci Center   (United States)

^d CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81255193631     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3370-7.00067-5     Document Type: Chapter

References (30)

1. Bax M., Goldstein M., Rosenbaum P., et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005, 47:571-576.
2. Beckung E., Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol 2002, 44:309-316.
3. Brin M.F., Aoki K.R. Botulinum toxin type A: Pharmacology. Spasticity: Etiology, Evaluation, Management, and the Role of Botulinum Toxin 2005, 110-124. WE MOVE, New York. N.H. Mayer, D.M. Simpson (Eds.).
4. Carlson W.E., Vaughan C.L., Damiano D.L., et al. Orthotic management of gait in spastic diplegia. Am J Phys Med Rehabil 1997, 76:219-225.
5. Dorman J., Pellegrino L. Making the diagnosis of cerebral palsy. Caring for Children with Cerebral Palsy 1998, 31-54. Brookes Publishing, Baltimore.
6. Dikel TN, Fennell EB Cognitive and neuropsychological functioning in children with cerebral palsy. J Child Neurol 2001, 16:58-63.
7. Gracies J.M., Elovic E., McGuire J., et al. Traditional pharmacologic treatments for spasticity, part I: Local treatments. Spasticity: Etiology, Evaluation, Management, and the Role of Botulinum Toxin 2005, 44-64. WE MOVE, New York. N.H. Mayer, D.M. Simpson (Eds.).
8. Gracies J.M., Nance P., Elovic E., et al. Traditional pharmacological treatments for spasticity, part II: General and regional treatments. Muscle Nerve Suppl 1997, 6:S92-S120.
9. Haflon N., Olson L.M. Introduction: Results from a new national survey of children's health. Pediatrics 2004, 113:1895-1898.
10. Hagglund G, Andersson S, Duppe H Prevention of severe contractures might replace multilevel surgery in cerebral palsy: Results of a population-based health care programme and new techniques to reduce spasticity. j Pediatr Orthop B 2005, 14:269-273.
11. Liptak G.S. Complementary and alternative therapies for cerebral palsy. Ment Retard Dev Disabil Res Rev 2005, 11:156-163.
12. McBurney H., Taylor N.F., Dodd K.J., et al. A qualitative analysis of the benefits of strength training for young people with cerebral palsy. Dev Med Child Neurol 2003, 45:658-663.
13. Mercuri E., Cowan G., Gupte G., et al. Prothrombotic disorders and abnormal neurodevelopmental outcomes in infants with neonatal cerebral infarction. Pediatrics 2001, 107:1400-1404.
14. Miller G. Cerebral palsies: An overview. The Cerebral Palsies: Causes, Consequences, and Management 1998, 1-35. Butterworth-Heinemann, Boston. G. Miller, G.D. Clark (Eds.).
15. Murphy N.A., Irwin M.C., Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications. Arch Phys Med Rehabil 2002, 83:1721-1725.
16. Nelson K.B., Ellenberg J.H. Antecedents of cerebral palsy-multivariant analysis. N Engl J Med 1986, 315:81-86.
17. Odding E., Roebroeck M.E., Stam H.J. The epidemiology of cerebral palsy: Incidence, impairments and risk factors. Disabil Rehabil 2006, 28:183-191.
18. Pharoah P., Cooke T., Rosenbloom L. Acquired cerebral palsy. Arch Dis Child 1989, 64:1013-1016.
19. Rudank S.L., Fellman V., Laatikainen L. Visual impairment in children born prematurely from 1972-1989. Ophthalmology 2003, 110:1639-1645.
20. Russman B.S., Ashwal S. Evaluation of the child with cerebral palsy. Semin Pediatr Neurol 2004, 11:47-57.
21. Sanger T.D., Delgado M.R., Gaebler-Spira D., et al. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003, 111:e89-e97.
22. Shaw B.N. The respiratory consequences of neurological deficit. Feeding the Disabled Child. Clinics in Developmental Medicine No. 140 1996, 40-46. Cambridge University Press, New York. P.B. Sullivan, L. Rosenbloom (Eds.).
23. Simonds A.K. Ethical aspects of home long-term ventilation in children with neuromuscular disease. Paediatr Respir Rev 2005, 6:209-214.
24. Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Childs Nerv Syst 2001, 17:1-18.
25. Sullivan P., Lambert B., Rose M., et al. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol 2000, 42:674-680.
26. Surveillance of Cerebral Palsy in Europe A collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol 2000, 42:816-824.
27. Taub E., Ramey S.L., DeLuca S., et al. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics 2004, 113:305-312.
28. Trauner D.A., Ballantyne A., Friedland S., et al. Disorders of affective and linguistic prosody in children after early unilateral brain damage. Ann Neurol 1996, 39:361-367.
29. Truwit C.L., Barkovich A.J., Kock T.K., et al. Cerebral palsy: MR findings in 40 patients. AJNR Am J Neuroradiol 1992, 13:67-78.
30. Zucconi M., Bruni O. Sleep disorders in children with neurologic disease. Semin Pediatr Neurol 2001, 8:258-275.